Cas:223532-05-6 3-Benzyl-1-(benzyloxy)-2-azetidinone manufacturer & supplier

Chemical Name:3-Benzyl-1-(benzyloxy)-2-azetidinone

CAS.NO:223532-05-6

Synonyms:3-Benzyl-1-(benzyloxy)-2-azetidinone

Molecular Formula:C₁₇H₁₇NO₂

Molecular Weight:267.32200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.54000

Exact Mass:267.12600

LogP:2.75720

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-Benzyl-1-(benzyloxy)-2-azetidinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Benzyl-1-(benzyloxy)-2-azetidinone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Benzyl-1-(benzyloxy)-2-azetidinone Use and application,3-Benzyl-1-(benzyloxy)-2-azetidinone technical grade,usp/ep/jp grade.

Related News: Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” 2-{[(tert-butoxy)carbonyl]amino}-3-cyclobutylpropanoic acid manufacturers The Ballina facility was first established in 1974 and was acquired by Charles River in 2002. Over the years it has added to its capabilities offering a comprehensive package of GMP services in support of recombinant biologics, vaccines, cell and gene therapies, biosimilars, and medical devices. Charles River now employs 230 people at two facilities in Ireland: the site in Ballina Co. Mayo which focuses on biologics testing, and a site in Dublin, established in 2017, which serves as the EMEA and APAC headquarters for the Company’s Microbial Solutions division. triethyloxidanium,hexafluorophosphate suppliers “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement. tert-butyl 4-aminopiperidine-1-carboxylate,hydrochloride vendor & factory He also mentioned that derivatives of these APIs and lot of other value-added APIs in the same range will also be manufactured at the new facility.,The Ballina facility was first established in 1974 and was acquired by Charles River in 2002. Over the years it has added to its capabilities offering a comprehensive package of GMP services in support of recombinant biologics, vaccines, cell and gene therapies, biosimilars, and medical devices. Charles River now employs 230 people at two facilities in Ireland: the site in Ballina Co. Mayo which focuses on biologics testing, and a site in Dublin, established in 2017, which serves as the EMEA and APAC headquarters for the Company’s Microbial Solutions division.